Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis
Authors
Keywords
Colorectal cancer, Cancer treatment, Cancer chemotherapy, Chemotherapy, Meta-analysis, Phase III clinical investigation, Surgical and invasive medical procedures, Surgical oncology
Journal
PLoS One
Volume 11, Issue 8, Pages e0161912
Publisher
Public Library of Science (PLoS)
Online
2016-09-01
DOI
10.1371/journal.pone.0161912
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial
- (2015) A. Passardi et al. ANNALS OF ONCOLOGY
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials
- (2014) Yan-xian Chen et al. Gastroenterology Research and Practice
- The Efficacy of Additional Bevacizumab to Cytotoxic Chemotherapy Regimens for the Treatment of Colorectal Cancer: An Updated Meta-Analysis for Randomized Trials
- (2013) Chao Lv et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
- (2013) David Cunningham et al. LANCET ONCOLOGY
- Relative Effectiveness and Safety of Chemotherapy in Elderly and Nonelderly Patients With Stage III Colon Cancer: A Systematic Review
- (2013) A. Hung et al. ONCOLOGIST
- Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials
- (2013) H. I. Hurwitz et al. ONCOLOGIST
- The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
- (2013) Limor Amit et al. PLoS One
- Differences in Survival between Colon and Rectal Cancer from SEER Data
- (2013) Yen-Chien Lee et al. PLoS One
- Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
- (2012) Ligia Traldi Macedo et al. BMC CANCER
- Bevacizumab in Stage II-III Colon Cancer: 5-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 Trial
- (2012) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Angiogenesis Inhibitor Bevacizumab on Survival in Patients with Cancer: A Meta-Analysis of the Published Literature
- (2012) Yuan Su et al. PLoS One
- Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial
- (2012) Zhong-Zhen Guan et al. Chinese Journal of Cancer
- Analysis of the seventh edition of American Joint Committee on colon cancer staging
- (2011) Yuan-Tzu Lan et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
- (2010) R. Labianca et al. ANNALS OF ONCOLOGY
- Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
- (2010) Niall C. Tebbutt et al. JOURNAL OF CLINICAL ONCOLOGY
- Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next?
- (2010) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study
- (2010) G.P. Stathopoulos et al. ONCOLOGY
- Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review
- (2009) S. Welch et al. ANNALS OF ONCOLOGY
- Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients
- (2009) Markus Moehler et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Undue reliance on I 2 in assessing heterogeneity may mislead
- (2008) Gerta Rücker et al. BMC Medical Research Methodology
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More